(Q38692084)

5 September 2017

title

Rationale for anti-CD137 cancer immunotherapy (English)

1 reference

5 September 2017

1 reference

Amani Makkouk

1

1 reference

5 September 2017

Cariad Chester

series ordinal

2

1 reference

5 September 2017

Holbrook E Kohrt

series ordinal

3

1 reference

5 September 2017

publication date

2 January 2016

1 reference

European Journal of Cancer

5 September 2017

published in

1 reference

5 September 2017

volume

54

1 reference

5 September 2017

page(s)

112-119

1 reference

Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer

5 September 2017

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1172/JCI61226

Targeting CD137 enhances the efficacy of cetuximab.

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1172/JCI73014

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies

1 reference

9 February 2024

https://opencitations.net/index/api/v1/citations/10.1182/BLOOD-2010-08-301945

Identifiers

DOI

10.1016/J.EJCA.2015.09.026

1 reference

release_7xkq5zq6jfgn5gvksvfeawx2jm

5 September 2017

Fatcat ID

1 reference

https://api.fatcat.wiki/v0/release/7xkq5zq6jfgn5gvksvfeawx2jm

Fatcat

reference URL

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference